Orthopedic research archive

Presenting this at rounds? Start here

• ?If short-term elastic compression shows no clinically meaningful benefit over sham, should clinicians stop recommending it as a stand-alone pain-relief strategy for knee OA, or is it still reasonable as an adjunct to encourage exercise participation?
• ?Given that both the sham and control groups also improved over time, how should this placebo/natural-history effect shape how surgeons counsel patients about the expected benefit of any conservative device-based therapy for knee OA?

Presenting this at rounds? Start here

• ?Should surgeons routinely reserve double-row fixation for tears measuring 30 mm or larger and default to single-row repair for smaller tears to save operative time?
• ?How should the finding that double-row reduces partial-thickness but not full-thickness retears change how aggressively clinicians image and monitor small tears postoperatively?

Presenting this at rounds? Start here

• ?This is a retrospective, non-randomized comparison using administrative EHR data with no direct measurement of bone mineral density, falls, physical activity, or medication adherence beyond fill counts; how much could residual confounding (E-value 1.83) explain an HR of 0.79?
• ?If GLP-1 RAs are confirmed to lower fracture risk in patients with diabetes but not in those without it, should orthopedic surgeons or endocrinologists factor fracture risk into the decision to prescribe GLP-1 RAs versus other second-line diabetes agents?

Presenting this at rounds? Start here

• ?The primary outcome (POD1 pain) showed many statistically significant pairwise differences that were then judged clinically insignificant using an externally sourced MCID of 1.86; how robust is that threshold, and could it be masking real differences in some subgroups?
• ?If no block meaningfully reduces day-1 pain, should a surgeon still choose PENG or intrathecal morphine purely for their opioid-sparing and length-of-stay benefits, and what does that mean for patients who cannot receive intrathecal morphine (e.g., outpatient/no spinal anesthesia)?

Presenting this at rounds? Start here

• ?If a patient starting HIV treatment is already overweight or obese, should regimen choice now factor in expected weight gain rather than defaulting to the standard dolutegravir/tenofovir alafenamide combination?
• ?Given the bone density loss and resistance signal seen with the doravirine-based regimen, how should clinicians weigh metabolic benefits against these competing risks when counseling patients?

Presenting this at rounds? Start here

• ?Given the large imbalances in myelopathy diagnosis, spondylolisthesis, and number of levels between groups (SMD as high as 1.195), how confident can we be that multivariable adjustment fully accounted for confounding by indication in choosing PCL versus PLF?
• ?If your institution predominantly performs PLF for multilevel cervical spondylotic myelopathy, would this registry data alone be enough to shift your practice toward laminoplasty, or would you want patient-reported outcome and alignment data before changing technique?

Presenting this at rounds? Start here

• ?For a patient with a simple (Schatzker I-III) tibial plateau fracture, would you now favor an arthroscopic-assisted approach over standard open fixation, and what factors (surgeon experience, equipment access) would influence that choice?
• ?How should this pooled complication and functional-outcome data change counseling for patients about expected recovery and reoperation risk after tibial plateau fracture surgery?

Presenting this at rounds? Start here

• ?If laminectomy carries roughly double the risk of incomplete tetraplegia at C1-C4 compared to laminoplasty, should laminoplasty be preferentially considered for patients needing decompression at these upper cervical levels?
• ?Given the higher 12-month mortality seen with laminectomy in this cohort, how should surgeons weigh unmeasured confounding by indication (e.g., patients selected for laminectomy with fusion, frailty, or more severe disease) when counseling patients about procedure choice?

Presenting this at rounds? Start here

• ?In an octogenarian with degenerative stenosis but no radiographic instability, how should this absolute mortality gap change the way you counsel about adding fusion versus doing decompression alone?
• ?If a patient has significant mechanical back pain suggesting possible occult instability not captured on imaging, how should surgeons balance the theoretical benefit of fusion against this study's mortality signal?

Presenting this at rounds? Start here

• ?Should a documented history of opioid-related disorder prompt routine preoperative screening or a dedicated care pathway before distal radius fracture repair?
• ?How might surgeons balance adequate postoperative pain control against opioid stewardship in patients with a known opioid-related disorder undergoing distal radius fracture repair?

Presenting this at rounds? Start here

• ?The control group received less clinician contact (up to 2 sessions) than the intervention group (4 sessions plus health coaching); how much of the early benefit could reflect nonspecific attention effects rather than swimming itself?
• ?Given that the benefit faded by 26-52 weeks alongside declining adherence, how would you counsel a patient about swimming as a long-term self-management strategy versus a short-term confidence-building tool?

Presenting this at rounds? Start here

• ?This is a single-center retrospective study with only 57 patients in the cognitive impairment subgroup; how much can we trust the stability of the interaction odds ratios (e.g., diabetes AOR 3.62, CI 1.18-11.07) given such small subgroup event counts?
• ?If a patient screens positive for cognitive impairment preoperatively, how should that concretely change your perioperative plan for glycemic control, frailty prehabilitation, and blood management before lumbar fusion?

Presenting this at rounds? Start here

• ?Given that fixation technique was chosen by surgeon preference rather than randomized, how might confounding by indication (e.g., compartment, graft morphology, surgeon skill) explain part of the observed difference in reoperation rates?
• ?If you were counseling a young patient with lateral meniscal deficiency, would this single-institution retrospective study be enough to steer you away from suture-only fixation, or would you want prospective confirmation first?

Presenting this at rounds? Start here

• ?If a 35-45 degree L4-S1 lordosis target were adopted as a routine intraoperative checkpoint, how should surgeons balance achieving it against added operative time, blood loss, or neural risk from more aggressive releases?
• ?For patients in whom anatomic constraints (rigid facets, sclerotic endplates) prevent reaching this lordosis target with TLIF, should surgeons instead default to an anterior approach (ALIF/OLIF) to achieve better sagittal correction?

Presenting this at rounds? Start here

• ?If a construct must stop at C7, does this data support prioritizing pedicle screw fixation at C7 over lateral mass screws to reduce failure risk?
• ?Should surgeons routinely extend the LIV into the upper thoracic spine (T1/T2) for degenerative or revision cases to avoid cervicothoracic junction failure, given the added operative time this requires?

Presenting this at rounds? Start here

• ?If the observed differences (effect sizes r=0.12-0.21) are statistically significant but below typical MCID thresholds for KSS and OKS, should surgeons change their alignment philosophy based on these results alone?
• ?Given that a larger, multicenter, blinded RASKAL trial found no differences between functional and mechanical alignment, how should a surgeon weigh a single high-volume operator's favorable results against that contrasting multicenter evidence when counseling patients about robotic TKA?

Presenting this at rounds? Start here

• ?Should routine gout management protocols incorporate mandatory DXA screening and fracture-risk assessment given the elevated fracture rates observed in this cohort?
• ?How should glucocorticoid dosing and duration be balanced against osteoporosis risk when treating recurrent gout flares in patients with comorbid CKD?

Presenting this at rounds? Start here

• ?If GAP score alignment targets don't predict mechanical complications in older Asian patients, should surgeons weight bone quality (e.g., Hounsfield units) or muscle mass more heavily than radiographic alignment when planning correction goals in this population?
• ?Given that well-aligned older patients still developed complications while some malaligned patients did not, should surgeons reconsider how aggressively they pursue GAP-defined 'proportioned' alignment in frail elderly patients if it doesn't reduce mechanical complication risk?

Presenting this at rounds? Start here

• ?Should surgeons preferentially offer robotic-assisted THA to patients with degenerative spinal stiffness even when they lack a formal fusion, given this study's finding that nonfused stiff-spine patients had similar risk reduction?
• ?How should the absence of a significant benefit in the spinal fusion subgroup change counseling and technique selection for patients who have already undergone lumbar fusion before THA?

Presenting this at rounds? Start here

• ?Given the retrospective design and unmeasured confounders like canal-occupying ratio, K-line status, and dural ossification, how much residual confounding could still be driving the observed complication differences even after multivariable adjustment?
• ?If corpectomy itself is not independently associated with complications once surgical extent is accounted for, should surgeons feel more comfortable choosing corpectomy when it offers a decompression advantage, or does the crude complication rate still matter for informed consent?